Rally Foundation is strongly focused on advancing pediatric cancer research and clinical science, channeling most of its support to leading children’s hospitals, academic medical centers, and dedicated childhood cancer research organizations across the U.S. Its grants overwhelmingly fund pediatric oncology studies, translational research and clinical trial work rather than general service delivery, and it repeatedly supports the same national research centers and university labs.
Concentrated, institutional giving characterized by multi-year and repeat grants to a relatively small set of national research centers and universities; majority of dollars go to large, project-focused grants (six-figure to seven-figure) rather than many small community grants.
Rally Foundation Inc concentrates its recent grantmaking on pediatric cancer research, with most of its largest awards going to children’s hospitals, academic medical centers, and research institutes running pediatric oncology studies. The foundation’s recent record shows repeated support for the same national research centers, especially Dana-Farber Cancer Institute, the Children’s Hospital of Philadelphia Research Institute, and St. Jude Children’s Research Hospital Inc, all funded for pediatric cancer study work. The pattern is research-forward rather than service-oriented. Grants are tied to clinical science, translational work, and study infrastructure, which points to a funder backing projects designed to advance treatment and understanding of childhood cancer. That emphasis appears across university-based labs and hospital research programs, including Emory University, Baylor College of Medicine, and Stanford University. Rally Foundation Inc also gives at a national scale. Its grants reach institutions in multiple regions of the United States, from Boston and Philadelphia to Houston, Seattle, and San Francisco. The giving pattern suggests a funder built around project-specific research support, with recurring relationships to established pediatric oncology centers rather than one-off local awards.
In pediatric oncology research, Rally Foundation Inc backed Dana-Farber Cancer Institute with $424,856 for a pediatric cancer study and also supported related study work there in earlier years. The same research orientation appears at the Children’s Hospital of Philadelphia Research Institute, which received $250,000 in 2024 for a pediatric cancer study and $175,000 in 2025 for the same purpose. Clinical research infrastructure is another clear theme. Baylor College of Medicine received $250,000 in 2024 and again in 2025 for pediatric cancer study work, while Emory University received $200,000 in 2025 for a pediatric cancer study after earlier awards for the same general purpose. The foundation also funds specialized childhood cancer research organizations. Curesearch for Children’s Cancer received $160,000 in 2024 and $150,000 in 2025, both for pediatric cancer study work, showing support for multi-year research activity rather than isolated grants.
$4.1M
$15.1M
$10.8M
$9.4M
Most grants fall between $50K and $100K, with a median of $50K.
25th Percentile
$50K
Median
$50K
75th Percentile
$100K
About 3% of grants go to recipients in CA.
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Notable grantees: Dana-Farber Cancer Institute, Emory University, Children's Hospital of Philadelphia (and its Research Institute), Baylor College of Medicine, St. Jude Children's Research Hospital
Typical grant size centers on $50,000 at the 25th percentile and median, with the 75th percentile at $100,000. The recent grants list also includes a higher tier of awards in the $150,000 to $424,856 range, mainly for research projects. The recipient list shows repeat awards to the same institutions across 2023, 2024, and 2025, including multiple pediatric cancer study grants to the same universities and hospitals. Rally Foundation Inc is a public charity and a regular funder. It also makes program-related investments.
Grant recipients are entirely U.S.-based in the available recent data, with 195 grants going to U.S. organizations. California is the top state by grant count. Recent awards land in major research hubs including Boston, Philadelphia, Baltimore, Atlanta, Houston, Memphis, Cincinnati, Seattle, and San Francisco. Georgia appears in the grants list through Atlanta-based recipients, but only 3% of grants go to recipients in the foundation’s HQ state.
The foundation primarily funds pediatric cancer research and clinical science. Recent grants support pediatric cancer studies at children’s hospitals, academic medical centers, research institutes, and university-based labs, with repeated awards for study work rather than general operating support.
Typical grant size is $50,000 at both the 25th percentile and the median, with the 75th percentile at $100,000. Recent awards also include larger research grants, ranging up to $424,856.
Yes. The recent grants list shows repeated awards across multiple years to organizations such as Dana-Farber Cancer Institute, Emory University, Baylor College of Medicine, the Children’s Hospital of Philadelphia, and Curesearch for Children’s Cancer.
Its giving is national, with all 195 grants in the recent country distribution going to U.S. recipients. California is the top state by grant count, and recent awards also appear in Boston, Philadelphia, Baltimore, Atlanta, Houston, Memphis, Cincinnati, Seattle, and San Francisco.
Yes. The foundation is classified as a regular funder and is listed as making program-related investments.
2025
Source: IRS Form 990-PF, fiscal year 2025.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| DANA FARBER CANCER INSTITUTE | BOSTON, MA | $424,856 | 2025 | PEDIATRIC CANCER STUDY |
| JOHN HOPKINS UNIVERSITY | BALTIMORE, MD | $382,709 | 2025 | PEDIATRIC CANCER STUDY |
| BAYLOR COLLEGE OF MEDICINE | HOUSTON, TX | $250,000 | 2025 | PEDIATRIC CANCER STUDY |
| ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | MEMPHIS, TN | $225,000 | 2025 | PEDIATRIC CANCER STUDY |
| CHILDREN'S HOSPITAL OF PHILADELPHIA | PHILADELPHIA, PA | $225,000 | 2025 | PEDIATRIC CANCER STUDY |
| EMORY UNIVERSITY | ATLANTA, GA | $200,000 | 2025 | PEDIATRIC CANCER STUDY |
| CHILDREN'S HOSPITAL MEDICAL CENTER | CINCINNATI, OH | $200,000 | 2025 | PEDIATRIC CANCER STUDY |
| THE CHILDREN'S HOSPITAL OF PHILADELPHIA RESEARCH INSTITUTE | PHILADELPHIA, PA | $175,000 | 2025 | PEDIATRIC CANCER STUDY |
| SEATTLE CHILDREN'S HOSPITAL DBA SEATTLE CHILDREN'S RESEARCH INSTITUTE | SEATTLE, WA | $150,000 | 2025 | PEDIATRIC CANCER STUDYPEDIATRIC CANCER STUDY |
| CURESEARCH FOR CHILDREN'S CANCER | BALTIMORE, MD | $150,000 | 2025 | PEDIATRIC CANCER STUDY |
| STANFORD UNIVERSITY | STANFORD, CA | $150,000 | 2025 | PEDIATRIC CANCER STUDY |
| CHILDREN'S RESEARCH INSTITUTE | WASHINGTON, DC | $125,000 | 2025 | PEDIATRIC CANCER STUDY |
| THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | DALLAS, TX | $125,000 | 2025 | PEDIATRIC CANCER STUDY |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | SAN FRANCISCO, CA | $112,500 | 2025 | PEDIATRIC CANCER STUDY |
| ICAHN SCHOOL OF MEDICINE MOUNT SINAI | NEW YORK, NY | $100,000 | 2025 | PEDIATRIC CANCER STUDY |
| LEUKEMIA & LYMPROME SOCIETY | RYE BROOK, NY | $100,000 | 2025 | PEDIATRIC CANCER STUDY |
| MEDICAL UNIVERSITY OF SOUTH CAROLINA | CHARLESTON, SC | $100,000 | 2025 | PEDIATRIC CANCER STUDY |
| THE ROCKEFELLER UNIVERSITY | NEW YORK, NY | $100,000 | 2025 | PEDIATRIC CANCER STUDY |
| THE UNIVERSITY OF CHICAGO | CHICAGO, IL | $75,000 | 2025 | PEDIATRIC CANCER STUDY |
| BOSTON CHILDREN'S HOSPITAL | BOSTON, MA | $75,000 | 2025 | PEDIATRIC CANCER STUDY |
| ALBERT EINSTEIN COLLEGE OF MEDICINE | BRONX, NY | $50,000 | 2025 | PEDIATRIC CANCER STUDY |
| NATIONAL CANCER INSTITUTE | BETHESDA, MD | $50,000 | 2025 | PEDIATRIC CANCER STUDY |
| FRED HUTCHINSON CANCER CENTER | SEATTLE, WA | $50,000 | 2025 | PEDIATRIC CANCER STUDY |
| SLOAN KETTERNING INSTITUTE FOR CANCER RESEARCH | NEW YORK, NY | $50,000 | 2025 | PEDIATRIC CANCER STUDYPEDIATRIC CANCER STUDY |
| CHILDREN'S CANCER THERAPY DEVELOPMENT INSTITUTE | HILLSBORO, OR | $50,000 | 2025 | PEDIATRIC CANCER STUDY |
| THE UNIVERSITY OF ALABAMA AT BIRMINGHAM | BIRMINGHAM, AL | $50,000 | 2025 | PEDIATRIC CANCER STUDY |
| RUTGERS THE STATE UNIVERSITY | NEW BRUNSWICK, NJ | $50,000 | 2025 | PEDIATRIC CANCER STUDY |
| SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE | LA JOLLA, CA | $50,000 | 2025 | PEDIATRIC CANCER STUDY |
| CHILDREN'S NATIONAL MEDICAL CENTER | WASHINGTON, DC | $50,000 | 2025 | PEDIATRIC CANCER STUDY |
| YALE UNIVERSITY | NEW HAVEN, CT | $50,000 | 2025 | PEDIATRIC CANCER STUDY |
| ARMS WIDE OPEN CHILDHOOD CANCER FOUNDATION | MARLBORO, NJ | $31,250 | 2025 | PEDIATRIC CANCER STUDY |
| CHILDREN'S HOSPITAL LOS ANGELES | LOS ANGELES, CA | $25,000 | 2025 | PEDIATRIC CANCER STUDY |
| UNIVERSITY OF UTAH | SALT LAKE CITY, UT | $25,000 | 2025 | PEDIATRIC CANCER STUDY |
| THE JOHN HOPKINS UNIVERSITY | BALTIMORE, MD | $25,000 | 2025 | PEDIATRIC CANCER STUDY |
| WASHINGTON UNIVERSITY | ST LOUIS, MO | $25,000 | 2025 | PEDIATRIC CANCER STUDY |
| ALTUM INC | RESTON, VA | $15,092 | 2025 | PEDIATRIC CANCER STUDY |
| THE PENNSYLVANIA STATE | HERSHEY, PA | $12,500 | 2025 | PEDIATRIC CANCER STUDY |
| JOHN HOPKINS UNIVERSITY | BALTIMORE, MD | $350,000 | 2024 | PEDIATRIC CANCER STUDY |
| DANA FARBER CANCER INSTITUTE | BOSTON, MA | $278,000 | 2024 | PEDIATRIC CANCER STUDY |
| BAYLOR COLLEGE OF MEDICINE | HOUSTON, TX | $250,000 | 2024 | PEDIATRIC CANCER STUDY |
| THE CHILDREN'S HOSPITAL OF PHILADELPHIA RESEARCH INSTITUTE | PHILADELPHIA, PA | $250,000 | 2024 | PEDIATRIC CANCER STUDY |
| CURESEARCH FOR CHILDREN'S CANCER | BALTIMORE, MD | $160,000 | 2024 | PEDIATRIC CANCER STUDY |
| ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | MEMPHIS, TN | $158,452 | 2024 | PEDIATRIC CANCER STUDY |
| SEATTLE CHILDREN'S HOSPITAL DBA SEATTLE CHILDREN'S RESEARCH INSTITUTE | SEATTLE, WA | $150,000 | 2024 | PEDIATRIC CANCER STUDYPEDIATRIC CANCER STUDY |
| THE UNIVERSITY OF ALABAMA AT BIRMINGHAM | BIRMINGHAM, AL | $120,986 | 2024 | PEDIATRIC CANCER STUDY |
| THE REGENTS OF THE UNIVERSITY OF MICHIGAN | WOLVERINE TWR, MI | $100,000 | 2024 | PEDIATRIC CANCER STUDY |
| ONCOHEROES BIOSCIENCES INC | — | $100,000 | 2024 | PEDIATRIC CANCER STUDY |
| OSTEOSARCOMA INSTITUTE | DALLAS, TX | $100,000 | 2024 | PEDIATRIC CANCER STUDY |
| SLOAN KETTERNING INSTITUTE FOR CANCER RESEARCH | NEW YORK, NY | $100,000 | 2024 | PEDIATRIC CANCER STUDYPEDIATRIC CANCER STUDY |
| EMORY UNIVERSITY | ATLANTA, GA | $100,000 | 2024 | PEDIATRIC CANCER STUDY |
PEDIATRIC CANCER STUDY
CHILDREN'S HOSPITAL MEDICAL CENTER
$200,000PEDIATRIC CANCER STUDY
PEDIATRIC CANCER STUDY
PEDIATRIC CANCER STUDYPEDIATRIC CANCER STUDY
STANFORD UNIVERSITY
$150,000PEDIATRIC CANCER STUDY
THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
$125,000PEDIATRIC CANCER STUDY
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
$112,500PEDIATRIC CANCER STUDY
ICAHN SCHOOL OF MEDICINE MOUNT SINAI
$100,000PEDIATRIC CANCER STUDY
MEDICAL UNIVERSITY OF SOUTH CAROLINA
$100,000PEDIATRIC CANCER STUDY
BOSTON CHILDREN'S HOSPITAL
$75,000PEDIATRIC CANCER STUDY
ALBERT EINSTEIN COLLEGE OF MEDICINE
$50,000PEDIATRIC CANCER STUDY
NATIONAL CANCER INSTITUTE
$50,000PEDIATRIC CANCER STUDY
SLOAN KETTERNING INSTITUTE FOR CANCER RESEARCH
$50,000PEDIATRIC CANCER STUDYPEDIATRIC CANCER STUDY
CHILDREN'S CANCER THERAPY DEVELOPMENT INSTITUTE
$50,000PEDIATRIC CANCER STUDY
THE UNIVERSITY OF ALABAMA AT BIRMINGHAM
$50,000PEDIATRIC CANCER STUDY
RUTGERS THE STATE UNIVERSITY
$50,000PEDIATRIC CANCER STUDY
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
$50,000PEDIATRIC CANCER STUDY
UNIVERSITY OF UTAH
$25,000PEDIATRIC CANCER STUDY
ALTUM INC
$15,092PEDIATRIC CANCER STUDY
THE PENNSYLVANIA STATE
$12,500PEDIATRIC CANCER STUDY
PEDIATRIC CANCER STUDY
PEDIATRIC CANCER STUDYPEDIATRIC CANCER STUDY
THE UNIVERSITY OF ALABAMA AT BIRMINGHAM
$120,986PEDIATRIC CANCER STUDY
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
$100,000PEDIATRIC CANCER STUDY
ONCOHEROES BIOSCIENCES INC
$100,000PEDIATRIC CANCER STUDY
OSTEOSARCOMA INSTITUTE
$100,000PEDIATRIC CANCER STUDY
SLOAN KETTERNING INSTITUTE FOR CANCER RESEARCH
$100,000PEDIATRIC CANCER STUDYPEDIATRIC CANCER STUDY